Tackling Sickle Cell Disease in Low-Resource Settings
AABB News spotlights three pioneering leaders in the blood and biotherapies community who are at the forefront of sickle cell disease research and advancing the treatment of the disease worldwide.
16 min read |Members Only |Feature
In this issue, AABB News highlights global advancements in sickle cell disease treatment.
2 min read |Open Access |President’s Message
Experts discuss the role of transfusion in managing sickle cell disease and explore how emerging novel therapies may result in transfusion independence.
9 min read |Members Only |Feature
In honor of World Sickle Cell Awareness Day, AABB News features warrior Jimi Olaghere, a gene therapy recipient and advocate for patients with sickle cell disease.
8 min read |Open Access |Feature
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
